CVS, Walmart reach $147.5 million opioid settlement with West Virginia -attorney general

This post was originally published on this site

https://i-invdn-com.investing.com/trkd-images/LYNXMPEI8J12S_L.jpg

West Virginia had been prepared to proceed to trial on Sept. 26 against those two companies and Walgreens Boots Alliance (NASDAQ:WBA).

The state had accused the pharmacy chains of fueling the deadly opioid epidemic through their allegedly lax oversight of prescription pills sold in the state.

Walgreens has not settled, and a trial has been rescheduled for June 2023.

“We believe that we have a very strong case against Walgreens,” Morrisey said at a news conference. “We’re going to pursue that quite vigorously.”

The state has been particularly hard hit by the epidemic, with a per capita opioid mortality rate over three times the national average in 2020, according to data from the National Center for Health Statistics.